Open Access

Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected

  • Stephanie L. Cumberworth1,
  • Jennifer A. Barrie2,
  • Madeleine E. Cunningham2,
  • Daniely Paulino Gomes de Figueiredo2,
  • Verena Schultz2,
  • Adrian J. Wilder-Smith2,
  • Benjamin Brennan1,
  • Lindomar J. Pena3,
  • Rafael Freitas de Oliveira França3,
  • Christopher Linington2,
  • Susan C. Barnett2,
  • Hugh J. Willison2,
  • Alain Kohl1Email author and
  • Julia M. Edgar2, 4Email author
Contributed equally
Acta Neuropathologica CommunicationsNeuroscience of Disease20175:50

https://doi.org/10.1186/s40478-017-0450-8

Received: 31 May 2017

Accepted: 2 June 2017

Published: 23 June 2017

Abstract

The recent global outbreak of Zika virus (ZIKV) infection has been linked to severe neurological disorders affecting the peripheral and central nervous systems (PNS and CNS, respectively). The pathobiology underlying these diverse clinical phenotypes are the subject of intense research; however, even the principal neural cell types vulnerable to productive Zika infection remain poorly characterised. Here we used CNS and PNS myelinating cultures from wild type and Ifnar1 knockout mice to examine neuronal and glial tropism and short-term consequences of direct infection with a Brazilian variant of ZIKV. Cell cultures were infected pre- or post-myelination for various intervals, then stained with cell-type and ZIKV-specific antibodies. In bypassing systemic immunity using ex vivo culture, and the type I interferon response in Ifnar1 deficient cells, we were able to evaluate the intrinsic infectivity of neural cells. Through systematic quantification of ZIKV infected cells in myelinating cultures, we found that ZIKV infection is enhanced in the absence of the type I interferon responses and that CNS cells are considerably more susceptible to infection than PNS cells. In particular, we demonstrate that CNS axons and myelinating oligodendrocytes are especially vulnerable to injury. These results have implications for understanding the pathobiology of neurological symptoms associated with ZIKV infection. Furthermore, we provide a quantifiable ex vivo infection model that can be used for fundamental and therapeutic studies on viral neuroinvasion and its consequences.

Keywords

Zika virusTropismMurineCentral nervous systemPeripheral nervous systemMyelinAxon

Introduction

Zika virus (ZIKV; family Flaviviridae, genus Flavivirus) is a positive stranded, mosquito-borne RNA virus associated with the peripheral neuropathy, Guillain-Barré syndrome (GBS), as well as microcephaly and other congenital brain abnormalities [5, 6, 40, 95, 96]; the impact on embryos and subsequent developmental problems are now referred to as Zika congenital syndrome (for example see [51, 58]). The risk of microcephaly is highest if mothers are infected during the first trimester of pregnancy ([86] and references within) but it is likely other neurological phenotypes arise following infection at later developmental stages. How ZIKV causes GBS, classically triggered through autoimmune responses against bacterial and viral infections [22, 31], remains to be explored and the interplay between direct infection and para- or post-infectious autoimmunity needs clarification [90].

ZIKV is closely related to other mosquito-borne flaviviruses such as dengue (DENV), Japanese encephalitis (JEV), St. Louis Encephalitis (SLEV) and West Nile (WNV) viruses [29]. Originally isolated in Africa, the virus has emerged in many regions of the world that can sustain transmission by competent vectors. In the current outbreak in the Americas, ZIKV is believed to be transmitted mainly by Aedes aegypti mosquitoes [25].

A number of arthropod-borne flaviviruses are neurotropic, including mosquito-borne JEV, WNV and SLEV, but also tick-transmitted flaviviruses such as tick-borne encephalitis virus (TBEV) [71]. DENV is not generally considered neurotropic but has also been associated with neurologic disease [78]. Of the mosquito-borne flaviviruses, the neurological complications arising from JEV and WNV infection are documented best. JEV, an important pathogen across Asia, is associated with meningitis and encephalitis [54, 79], whilst WNV is linked with encephalitis, particularly in the elderly [56]; with long term neurological sequelae in convalescent patients [97].

At present, the determinants underlying ZIKV viral tropism (both host and viral) are unclear, although several hypotheses have been discussed [2]. Importantly, ZIKV has been shown to replicate in human placental and foetal cells [21], and virus has been found in human foetal tissues [18, 51, 55, 67, 73]. Studies in primates reproduce some of the effects seen in human infection, including brain lesions, confirming a causal link between ZIKV infection and neurological outcomes [1, 43]. Experimental studies on the neurotropism of ZIKV demonstrate it can infect human neural cell-derived organoid systems/neurospheres, neuroepithelial/neural stem cells and radial glia [15, 2628, 49, 64, 68]; variations in infection patterns and host responses have been attributed to differences between ZIKV strains [26, 75, 99]. Whilst there are few data on the neuropathogenesis of ZIKV infection, infected human-derived neural crest cells produce cytokines at levels that kill or cause aberrant differentiation of neural progenitors [4], and expression of genes involved in cell cycle and neural differentiation are altered in ZIKV-infected human iPS-cell derived neurospheres [28].

Mouse models have been used to study placental damage, infection of foetuses, testicular infection, neuropathogenesis, antibody protection and ZIKV strain specific effects [14, 24, 32, 41, 47, 52, 53, 72, 76, 80, 87]. Whilst animal models are undoubtedly important, cell culture systems (i) facilitate manipulation of experimental conditions, (ii) yield relatively rapid results and (iii) inform animal studies, thus refining and reducing the use of experimental animals. Here we infected CNS and PNS ‘myelinating’ cultures derived from embryonic wild type and type I interferon incompetent mice with a Brazilian, patient-derived isolate of ZIKV, to define neural tropism and short-term consequences of direct infection. Myelinating cultures, which replicate several aspects of the intact nervous systems, including complex cell-cell interactions, were infected pre- and post-myelination, mimicking late foetal and early postnatal life. We found that all major CNS cell types were susceptible to productive infection in type I interferon incompetent cultures and CNS axons and myelinating oligodendrocytes were particularly vulnerable to injury; an observation that might be important for understanding the less well-characterised neurological phenotypes in both microcephalic and non-microcephalic cases. In contrast, PNS infection rates were generally very low, even in absence of type I interferon responses, suggesting that GBS is unlikely the result of direct viral infection of the PNS.

Material and methods

Mouse breeding and genotyping

Ifnar1 knockout (KO; type I interferon incompetent) and wild type (WT) mice on a 129S7/SvEvBrdBkl-Hprtb-m2 background (B&K Universal) were maintained in Tecniplast 1284 L Blue line IVC cages, in a 12 h light/dark cycle and provided ad libitum with sterile food and water. Mice were time-mated and pregnant females were killed by CO2 overdose on embryonic day (E) 13. All animal studies were approved by the Ethical Committee of the University of Glasgow and licensed by the UK Home Office (Project Licence number PPL 60/4363). Genomic DNA was extracted from ear biopsies using a protocol modified from [88]. Briefly, ear notches were heated to 95 °C for 90 min in 50 mM NaOH. Following neutralisation with 10% v/v 1 M Tris pH 5, the resultant solution was vortexed to release DNA and 1 μl was used for PCR.

Genotyping

For PCR, RedTaq polymerase (Sigma Aldrich) was used. Briefly, each reaction contained 1× reaction buffer including 0.2 mM dNTPs, 0.2 μM primer, 0.05 U/μl polymerase and 1 μl ear biopsy lysate. An initial heating step of 95 °C for 2 min was followed by 35 cycles of 95 °C 1 min, 60 °C 1 min and 72 °C 2 min. For completion of syntheses, samples underwent a final step of 72 °C for 5 min before being cooled to 4 °C. The products were analyzed by agarose gel electrophoreses according to standard protocols.

Cell culture

CNS myelinating cultures were established as described previously [82, 83], with minor modifications. Briefly, E13 (day of plug E0) mouse spinal cords were isolated and stripped of their meninges then dissociated into a single cell suspension using trypsin and trituration through a glass pipette. Cells were plated at 150,000 cells per 13 mm diameter glass coverslips coated with poly-L-lysine (0.1 mg/ml in boric acid buffer pH 8.4); coverslips were located in 3 s inside 35 mm Petri dishes. Cells were plated initially in 12.5% horse serum, which was gradually withdrawn through feeding every 2nd or 3rd day with serum-free differentiation medium (DMEM [4.5 mg/ml glucose], 100 U/ml penicillin, 100 μg/ml streptomycin, 10 ng/ml biotin, 1% N1, 50 nM hydrocortisone, and 10 μg/ml insulin; the last for the first 12 days only. All reagents were from Sigma-Aldrich, Dorset, UK. Cells were maintained in 5% C02 at 37 °C. PNS myelinating cultures were established as described previously [66], with modifications. Briefly, whole dorsal root ganglia (DRG) were plucked from the E13 mouse spinal cord meninges with fine forceps and plated singly onto Matrigel (1:3 in EMEM)/poly-D-lysine (0.1 mg/ml) coated 13 mm diameter coverslips in 80 μl growth media (MEM [4 mg/ml glucose], 100 U/ml penicillin, 100 μg/ml streptomycin, 10% horse serum, 50 ng/ml nerve growth factor). DRGs were cultured overnight before a further 400 μl growth medium was added. They were maintained throughout in 5% CO2 at 37 °C. At day in vitro (DIV) 8, growth medium was replaced with myelinating medium (MEM [4 mg/ml glucose], 100 U/ml penicillin, 100 μg/ml streptomycin, 5% horse serum, 50 ng/ml nerve growth factor, 1% N2, 20 μg/ml bovine pituitary extract, 0.5 μM forskolin, 50 μg/ml ascorbic acid) and 50% was exchanged with fresh medium every 2–3 days. Reagents were from Sigma-Aldrich, Dorset, UK or Invitrogen, Paisley, UK.

Infection of cultures with ZIKV

The low passage Brazilian strain of ZIKV, ZIKV/H. sapiens/Brazil/PE243/2015 (GenBank accession number KX197192; abbreviated ZIKV PE243; in this paper referred to only as ZIKV) was used; its origin and history have been previously described [17]. Both CNS and PNS cultures were transported between geographically separated sites at room temperature in a sealed container containing 5% CO2 and allowed to equilibrate at 37 °C in 5% CO2 overnight. CNS/PNS cultures (minimum of 20 or 12 coverslips, respectively, per independent experiment) were infected with ZIKV at a multiplicity of infection (MOI) of 0.3 or 3.0 for 1 h at 37 °C in PBS supplemented with 2% foetal bovine serum (FBS). Controls (mock-infected; minimum of 5 CNS and 6 PNS coverslips per independent experiment) were treated in parallel with vehicle only (2% FBS in PBS). Following incubation, virus was aspirated and the cultures returned to serum-free differentiation medium (CNS) or myelination medium (PNS). At the indicated times post infection, cultures were fixed with 8% paraformaldehyde for 1 h at room temperature and subsequently stored in PBS at 4 °C for up to 2 weeks before staining. CNS/PNS cultures utilised in 6/12 days post infection (dpi) experiments were infected as described, and maintained with media replenishments every 2 days until fixation at 6/12 dpi before fixation, as described above.

Test for anti-ZIKV proliferative effect of PNS culture media

To test if the media in which the DRG explants were maintained was inhibitory to ZIKV replication, A549 cells (a human cell line which we have previously characterised for ZIKV infection [17]) were infected with ZIKV at MOI 0.3 and maintained for 72 h post infection (hpi) in (i) DMEM GlutaMAX supplemented with either 10% horse serum (used to supplement PNS myelinating media), 10% FBS (used to maintain A549 cells) or (ii) PNS myelinating media supplemented with either 10% FBS or 10% horse serum. At 72 hpi cells were fixed with 8% paraformaldehyde and analysed by immunofluorescence using an antibody directed against the ZIKV envelope protein (clone 0302156 Aalto Bio; 1 in 500). Imaging was performed using an EVOS Fl microscope.

Immunocytochemistry

Post-fixation, myelinating cultures were permeabilised in ethanol (−20 °C; 10 min) and incubated in primary antibodies in 10% goat serum overnight at 4 °C. Mouse anti-ZIKV [clone 0302156 Aalto Bio; 1 in 500] was used in combination with one or other of the following cell-type specific antibodies: rat anti-PLP/DM20 [Clone AA3, kindly provided by Dr. Steven Pfeiffer, Connecticut; 1 in 400]; rabbit anti-NeuN [Millipore; 1 in 750], rabbit anti-S100 [Dako; 1 in 400], rabbit anti-GFAP [Dako; 1 in 1000], rabbit anti-NG2 [Millipore; 1 in 200], rat anti-MBP [AbD serotec; 1 in 500], or rat anti-F480 [AbD serotec; 1in 600]). Rat anti-MBP was also used in combination with mouse SMI31 anti-phosphorylated heavy and medium chain neurofilament [Biolegend; 1 in 1500] and rat anti-F480 in combination with mouse SMI32 anti-non-phosphorylated neurofilament heavy chain [Sternberger; 1 in 1500] or mouse anti-β-Tubulin III [Sigma; 1 in 200]. After washing, secondary antibodies (goat anti-mouse IgG1 Alexa 488 and goat anti-rat IgG or goat anti-rabbit IgG or goat anti-mouse IgG2a Alexa 594; Invitrogen) were applied for 1 h at room temperature. Coverslips were mounted on glass slides in Citifluor mounting medium with DAPI (1 ng/ml; Electron Microscopy Sciences Pennsylvania US) and sealed with nail enamel.

Image capture

For cell quantification, fluorescence microscopy and image capture were performed using an Olympus IX70 microscope with standard epifluorescence optics and Image Pro Plus 6 software. To avoid bias, fields of view (FoV) were selected in the blue (DAPI) channel then images were captured (10 images per coverslip) at ×20 magnification in the red (cell-type specific), green (ZIKV) and blue channels. Representative images for illustration were obtained using the Olympus IX70 microscope and Image Pro Plus 6 software; a Zeiss LSM 710 inverted confocal microscope and Zen Black software; or a Zeiss AxioImager Z1 with ApoTome structural illumination attachment and Zeiss Zen 2 software.

Quantification of cells

Rectangular areas of interest (AoI) of 148,427 μm2 and 20,000 μm2 were placed on each image and immunostained cells or DAPI +ve nuclei, respectively, within and touching west and north borders were quantified. Only immunopositive structures with a DAPI +ve nucleus qualified as cells. The average cell density per AOI was converted to cells/mm2 using the formula: cell density per AOI/area of AOI μm2 × 1,000,000. Pyknotic nuclei were distinguished from healthy nuclei on the basis of size, and homogeneity and intensity of DAPI staining; pyknotic nuclei being condensed and intensely labelled.

Quantification of CNS myelin

Anti-MBP labels mainly myelin and myelin-like sheaths whilst anti-PLP/DM20 labels myelin, myelin-like sheaths and oligodendrocyte cell bodies. Using digital images of representative fields of view of immunostained cultures, the area occupied by MBP or PLP/DM20 staining (pixels per AOI) was quantified using CellProfiler software. Pipelines are available at https://github.com/muecs/cp.

Statistical analysis

Analyses were performed using Graphpad Prism4 software (GraphPad Software Inc., San Diego, CA). Significance is indicated as <0.05 (*), <0.01 (**) and <0.001 (***). A paired, one or two tailed Student’s t test was used to compare cell densities/myelin area between mock -infected and ZIKV-infected cultures, using n = 3 independent cultures i.e. cultures generated from 3 independent pregnant dams (2–4 coverslips per cell type and 12–20 coverslips per DAPI count were quantified and averaged for each independent culture).

Results

ZIKV infection is enhanced in the absence of type I responses

To determine the intrinsic infectivity of neural cells by a Brazilian strain of ZIKV (ZIKV PE243, see Materials and methods), we prepared myelinating (i) mixed spinal cord cell and (ii) dorsal root ganglia explant cultures to model the multi-cellular environment of the CNS and PNS, respectively. Cultures were prepared from WT and Ifnar1 KO (type I interferon deficient) mouse embryos. Ifnar1 KO cultures were indistinguishable from WT cultures with respect to cellular composition and myelination (Additional file 1: Figure S1a and b [CNS] and 1c and d [PNS]).

To test if ZIKV is type I interferon dependent in this system, we infected WT and Ifnar1 KO cultures DIV 28, after myelin is established. We treated cultures for 1 h with ZIKV MOI 0.3 or ZIKV MOI 3.0, and fixed the cultures after 24 or 72 h, respectively; the latter was done to increase the opportunity for productive infection. Mock-infected controls were treated with vehicle only. In CNS cultures, markedly more cells were infected in the absence of interferon alpha/beta receptor subunit 1 (IFNAR1), particularly at 72 hpi (compare Fig. 1a with 1b and 1e with 1f). In PNS cultures, the percentage of infected cells was barely above the level of ‘false-positives’ in mock-infected controls, even in the absence of IFNAR1 (Fig. 1c–h). Thus, this Brazilian ZIKV strain is inhibited by type I interferon responses in CNS neural cell cultures, as in other cell types [17], and CNS cells are markedly more susceptible to infection than PNS cells.
Fig. 1

ZIKV infection is limited by the type I interferon response in neural cell cultures. a-d Micrographs of infected cells in myelinating cultures from wild type (WT) CNS (a), Ifnar1 knockout (KO) CNS (b), WT PNS (c) and Ifnar1 KO PNS (d) infected with a multiplicity of infection (MOI) of 3.0 for 72 h. Bar: 100 μm. e, f, Graphs of total (grey bars) and infected (black bars) cell densities in mock infected and ZIKV infected CNS cultures at MOI and hours post infection (hpi) indicated. The percentage of infected cells is indicated above each bar. Compared to wild type cultures, more cells are infected in the absence of a type I interferon response. g, h Graphs of total and infected cell densities in PNS cultures. Note the different scale on the lower Y axis. Infection rates are very low even in the absence of a type I interferon response. There is a proportion of cells that are false positives, as indicated by black bars in the mock infected cultures. Bars represent mean ± SD; n = 3 for all except ‘WT CNS’ and ‘WT PNS mock’ where n = 2

ZIKV infects all major CNS neural cell types

To determine which CNS neural cell types are most susceptible to ZIKV infection, we examined cell-type specific infection at 24 hpi (ZIKV MOI 0.3). In WT cultures, we found evidence for ZIKV in all major cell types except neurones, however the proportion of ZIKV +ve cells, being only 2.4% of all cells (n = 2; Fig. 1e), was barely above background levels observed in mock-infected cultures. Consequently, we did not pursue this analysis.

In Ifnar1 KO cultures, ZIKV was observed to varying extents in all major cell types with the possible exception of neurones which occasionally appeared positive even in mock-infected cultures (Fig. 2a-e illustrates infected cells following ZIKV infection at MOI 0.3 or 3.0 for 24 or 72 hpi, respectively). Overall, the densities of ZIKV +ve Ifnar1 KO cells were, in decreasing order: oligodendrocyte precursor cells (OPCs), mature oligodendrocytes, astrocytes, neurones and microglia. In these CNS cultures, astrocytes, OPCs and neurones are each present at approximately three times the density of microglia or mature (PLP/DM20 + ve) oligodendrocytes (Fig. 2f). Taking their relative abundance into account, the proportion of each cell type that is ZIKV +ve is, in decreasing order: mature oligodendrocytes (24%), OPCs (12%), microglia (6%), astrocytes (3%) and neurones (3%) (Fig. 2g). We cannot exclude the possibility that the ZIKV +ve staining in microglia is due to phagocytosis of infected material, with or without subsequent replication, rather than direct infection.
Fig. 2

ZIKV infects all principal CNS cell types. a-e Micrographs of infected neural cell types from Ifnar1 KO cultures at 24 or 72 hpi with ZIKV. a NeuN-labelled neurone (b) GFAP-labelled astrocyte; inset shows an example of an infected cell in which the glial fibrils appear condensed, ​(c) PLP/DM20-labelled oligodendrocyte (white arrow) with a fragmented myelin sheath (broken yellow arrow), below which there is normal-appearing myelin sheath (solid yellow arrow), (d) NG2-labelled OPCs and (e) F480-labelled microglial cell, all containing detectible levels of ZIKV. Bars: 10 μm. f-h Graphs showing densities of total (grey) and infected (black) cells in Ifnar1 knockout mouse cultures, treated with vehicle (f; mock), ZIKV at MOI 0.3 24 hpi (g) or ZIKV at MOI 3.0 72 hpi (h).​ In mock infected cultures a small number of cells appeared positive for ZIKV and represent false positives. Bars represent mean ± SD; n = 3 for all except ‘microglia MOI 0.3 24 hpi’ where n = 2

As stated above, the titre of ZIKV in the CNS is unknown and will vary spatially and temporally within and between individuals therefore we raised the MOI to 3.0 and the post-infection time to 72 h, as described above. In WT cultures, the proportion of infected cells remained low at 3.9% (n = 2; Fig. 1e), but a small proportion of all major cell types, except neurones, were ZIKV +ve (data not shown). In Ifnar1 KO mouse cultures, all major cell types including neurones harboured detectable levels of virus at this time point (Fig. 2h). Compared to 24 hpi MOI 0.3, there was a change in susceptibility to infection, with the densities of infected cells being, in decreasing order: astrocytes, microglia, neurones, OPCs and mature oligodendrocytes. The relative density of each cell type was not markedly different from that in mock-infected controls (compare grey bars in Fig. 2f and h), suggesting that the composition of the cultures did not change with infection. Taking their relative abundance into account, the proportion of each cell type infected was, in decreasing order: mature oligodendrocytes (45%), microglia (34%), astrocytes (26%), OPCs (11%) and neurones (9%) (Fig. 2h). Most notably, the proportion of infected microglia and astrocytes increased ~5- and ~8-fold, respectively, compared to 24 hpi (MOI 0.3). Despite the longer post-infection time, most infected cells appeared morphologically normal, though a small number of astrocytes were misshapen and the GFAP staining pattern suggested the cytoskeletal filaments were condensed (Fig. 2b insets).

In summary, all major CNS cell types are susceptible to infection in the absence of a type I interferon response, but mature oligodendrocytes are particularly sensitive. Remarkably, compared to the other cell types, there is a disproportionate increase in the percentage of microglia and astrocytes that are infected at 72 hpi (MOI 3.0) relative to 24 hpi (MOI 0.3).

ZIKV infection is highly pathogenic in CNS cultures

Whilst the CNS cultures and most of their composite cells appeared relatively normal following infection with ZIKV under the conditions described above, we next asked whether ZIKV infection resulted in cell death. In Ifnar1 KO cultures, 4% (n = 3) and 12% (n = 3) of DAPI +ve nuclei were pyknotic at 24 hpi and 72 hpi following infection with ZIKV with an MOI of 0.3 and 3.0, respectively, compared to 3% (n = 3) in mock-infected controls. We then examined cell type specific vulnerability and found significant increases in dead/dying microglia at both time points and of astrocytes at 72 hpi (Fig. 3a; n = 3). There was a trend for PLP/DM20 + ve oligodendrocytes to be susceptible too, but values did not reach significance (Fig. 3a; n = 3).
Fig. 3

ZIKV infection of CNS cultures causes cell death. a, b Graphs of percentage of pyknotic nuclei of each major neural cell type at the post-infection (hpi) time points and MOI indicated. Cell death was assessed on the basis of DAPI +ve nuclear morphology (see M&M). Statistically significant differences relative to mock infected controls (green) are indicated by stars. c-e Graphs of total densities (grey bars) and infected cell densities (black bars) of each of the 5 major neural cell types at the day of infection (Day 0; c) and at 6 days post infection (dpi) in mock (d) and ZIKV (e) infected cultures. Percentage infected is indicated above each bar. f Graph of healthy nuclei (grey bars) and pyknotic nuclei (black bars) at day 0 and at 6 dpi in mock infected or ZIKV infected cultures. There is a significant increase in the density of pyknotic nuclei (average 26%) in ZIKV infected cultures compared to mock infected controls (average 5%), although the reduction in the density of healthy nuclei in ZIKV infected cultures does not reach significance. Bars represent mean ± SD; n = 3 except DIV 0 counts which are from one experiment only. * = p ≤ 0.05; ** = p ≤ 0.01

Next we asked if longer-term infection is pathogenic, using Ifnar1 KO cultures. To address this we treated cultures on DIV 18 (± 2 DIV), when myelin is just beginning to form, with vehicle or ZIKV using an MOI of 0.3 for one hour then assessed cellular composition, myelination and neurite densities at 6 days post infection (dpi).

We observed a significant increase in the proportion of dying oligodendrocytes, OPCs and microglia in ZIKV infected cultures compared to controls (Fig. 3b). In terms of cell-type specific infectivity, ZIKV was detectable in 34% of astrocytes 26% of oligodendrocytes, 24% of microglia, 8% of neurones and 8% of OPCs (Fig. 3e). Despite this, the density of each of the principal neural cell types was not altered markedly in ZIKV infected cultures (Fig. 3e) compared to mock infected controls (Fig. 3d). Nonetheless, infection was accompanied by a slight diminution in total densities of healthy appearing nuclei and a significant increase in total pyknotic nuclei (Fig. 3f).

Strikingly, although we observed no significant decrease in either oligodendroglial or neuronal densities under these conditions (grey bars, Fig. 3d and e), ZIKV infection was associated with a significant decrease in myelin (Fig. 4) as assessed by PLP/DM20 + ve immune reactivity (Fig. 4q). MBP staining was also consistently and markedly reduced, although the reduction did not reach significance due to large variation between different cultures (Fig. 4r). PLP/DM20 and MBP are located in compact myelin, so we examined a 4th independent culture using antibodies to sulphatide, a myelin lipid, and myelin oligodendrocyte glycoprotein (MOG), a protein on the surface of the mature myelin sheath. Both were diminished in ZIKV-infected cultures (Additional file 2: Figure S2). These myelin changes were accompanied by a pronounced qualitative decrease in axons as indicated by antibody staining for phosphorylated neurofilament (compare Fig. 4k and l with g and h), non-phosphorylated neurofilament (compare Fig. 4n with m) and β tubulin 3 (compare Fig. 4p with o). How ZIKV mediates these effects is currently unknown. However, many cells (including oligodendrocytes) had an abnormal morphology (Fig. 4i, inset; Fig. 5) and many neuronal cells bodies were positive for phosphorylated neurofilament heavy and medium chains; an indication of pathology (Fig. 4k and l).
Fig. 4

ZIKV infection injures CNS myelin and axons in Ifnar1 knockout mouse myelinating cultures. Antibody AA3 to PLP/DM20 labels oligodendrocyte cell bodies whilst both AA3 and anti-MBP label myelin-like sheaths at 18 (a, b, d) and 24 days in vitro (DIV) (e, f, h, i, j and l). Antibody SMI31 labels phosphorylated heavy and medium chain neurofilament at 18 (c) and 24 DIV (g, k). h, l Both myelin and axons are diminished in ZIKV infected cultures compared to mock infected cultures. Most of the remaining myelin in ZIKV infected cultures appears fragmented (inset in i versus inset in e). In contrast to controls, ZIKV infected cultures contain many neuronal cell bodies filled with phosphorylated neurofilament (yellow arrow k, l). d, h and l Deterioration of neurites (axons and dendrites) in ZIKV infected cultures can also be visualized using antibodies to β tubulin 3 (microtubules) and non-phosphorylated neurofilament (SMI32; compare n and p to m and o). In n, only a few neurites (white arrows) are visible and, whilst normal-appearing neuronal cell bodies are labelled in mock infected cultures (yellow arrows in m), those in the infected cultures appear abnormal (yellow arrows in n). q, r Graphs showing mean percentage of pixels that are PLP/DM20 or MBP positive per area of interest; bars represent mean of 3 independent experiments ± SD. Bars: 50 μm,​ * p ≤ 0.05

Fig. 5

ZIKV infection leads to changes in principal neural cell types in Ifnar1 knockout cultures. a and a i overlay F480-labelled microglia appear to engulf pyknotic nuclei (white arrows) and possibly also ZIKV-infected cells (yellow arrow). bb overlay, c, c i overlay Some infected astrocytes appear relatively normal, with filamentous-appearing GFAP staining (b), whereas in other cases the filaments appear condensed (c). d i The majority of oligodendrocyte precursors were not infected and appeared normal. A proportion of PLP/DM20 positive oligodendrocytes was not infected and retained their myelin sheaths, e i whereas many of these cells were infected and appear morphologically abnormal with absent myelin sheaths (see Fig. 4). f, f i overlay Occasionally neurones were infected and had ZIKV +ve puncta in the cell body and in processes leading from the cell body. In infected neurons and oligodendrocytes, the nucleus often appeared to be displaced to the edge of the soma, as in this case

At this time point, some microglia appeared to be in the process of phagocytosing pyknotic nuclei (Fig. 5a) and although many infected astrocytes had normal-appearing GFAP staining (Fig. 5b), filaments appeared condensed in many cells (Fig. 5c). The majority of OPCs were not infected and appeared normal (Fig. 5d) and occasional myelinating oligodendrocytes retained long stretches of smooth myelin (Fig. 5e). ZIKA +ve puncta could be observed in some neuronal cell bodies and in processes (likely dendrites and axons) extending from the soma (Fig. 5f).

In summary, mature oligodendrocytes and axons, but not neuronal cells bodies (as determined with antibody to NeuN) are numerically attenuated following long-term (6 day) infection of CNS cells with ZIKV, and myelin pathology is likely the secondary response to one or other, or both of these events.

PNS cells are markedly less susceptible to ZIKV infection than CNS cells

As ZIKV infection can cause GBS, we next examined the PNS cultures described briefly above, in more detail. Occasional neurones, Schwann cells and macrophages (as assessed by positive staining for NeuN, S100 and F480 respectively) appeared ZIKV +ve at 72 hpi following infection with ZIKV at MOI 3.0 (Fig. 6a-d), however the overall levels of infection were barely above background levels, even in Ifnar1 KO cultures. Background immune reactivity was particularly prominent in macrophages, most likely due to the presence of autofluorescent lipofuscin positive granules (Fig. 6b). Nonetheless a few Schwann cells and DRG neurones were considered to be definitively positive for ZIKV (Fig. 6a, c and d). This low level of infection was not due to the presence of inhibitory factors in the culture medium as this media had no effect on the ability of ZIKV to infect A549 cells (data not presented). Even at 12 dpi ZIKV (MOI 0.3), cultures appeared healthy with no overt signs of axonal or myelin pathology or cell death (Additional file 2: Figure S2i).
Fig. 6

Rarely, DRG neurones and Schwann cells are positive for ZIKV in PNS cultures. a-d Micrographs of Ifnar1 knockout (KO) PNS cultures infected with an MOI of 3.0 for 72 hpi. a Overview of a NeuN and ZIKV-labelled culture to illustrate the low overall level of neuronal infection (green arrows indicate rare infected cells). Bar: 100 μm. b F480 positive macrophage in which green lipofuscin puncta can be mistaken for ZIKV immunostaining as indicated by the level of false ZIKV-positive macrophages observed in mock infected cultures. c ZIKV infected MBP-labelled Schwann cell (i) and infected and non-infected S100-labelled Schwann cells (ii and iii, respectively). d NeuN-labelled neurones, one of which is infected with ZIKV (green arrow). Bars: 20 μm. e-j Graphs of cell-type specific densities (grey bars) and infected cell densities (black bars) in wild type (WT) (e-g) and Ifnar 1 KO cultures (h-j). Many macrophages appeared positive for ZIKV in mock-infected cultures, suggesting that many of the macrophages quantified in (f, g, i and j) represent false positives. Bars represent mean ± SD; n = 3 for all graphs except mock infected wild type where n = 2

In summary, our data suggest the PNS is relatively resistant to infection, at least with this ZIKV strain in this ex vivo system.

Discussion

Understanding the tropism of ZIKV is key to understanding the pathogenesis of ZIKV infection. Here we demonstrate that a Brazilian strain of ZIKV isolated from a patient with no reported neurological symptoms [17], infects and injures CNS cells in murine myelinating cultures. Our data demonstrate that oligodendrocytes are particularly susceptible to infection, although all major CNS neural cells were targeted to varying degrees. Importantly, white matter components -axons and myelinating oligodendrocytes- were particularly vulnerable to ZIKV-induced injury. In contrast, the virus rarely infected PNS cells from the same mouse embryos. Although it would be naïve to discount effects due to viral strain and host species-specific effects, these observations shed new light on the pathobiology of ZIKV-associated neurological syndromes. First, as the cultures model late foetal and early postnatal stages of development in the human nervous system they are valuable for investigating the pathogenesis of neurological symptoms other than microcephaly, which is thought to result predominantly from infection in the 1st trimester [23, 86]. Second, the vulnerability of myelinating oligodendrocytes might explain the extensive white matter pathology associated with congenital ZIKV syndrome. Finally, the inability of ZIKV to productively infect PNS cultures would suggest Zika-GBS is unlikely to be due to direct infection of the PNS, it being more likely Zika-GBS is due to para- or post-infectious autoimmunity, which is the typically recognised pathogenesis pathway for other infection-related forms of GBS.

ZIKV infection injures white matter structures

Many studies on the pathogenesis of ZIKV have focussed on the proliferation, survival and differentiation of CNS neural precursors; the use of iPS derived human cells conferring species-specific relevance, in some studies [4, 15, 27, 28, 41, 46, 49, 64, 68, 70, 91, 99]. However, it is not currently possible, using human cells, to generate in vitro models of the relatively more mature nervous systems, comprising differentiated neurones and glia and myelinated nerve fibres. Here we took advantage of murine model systems that mimic these aspects, enabling us to identify CNS myelinating oligodendrocytes and axons as particularly vulnerable to ZIKV-induced injury.

Notably, axonal changes occurred in the absence of overt infection or death of neurones. This suggests axons could be injured by soluble or contact-dependent factors in their environment. Previously it has been shown that ZIKV-infected neural crest cells produce cytokines at levels that kill or cause aberrant differentiation of neural progenitors [4]. To date however, the only soluble factor that has been demonstrated unequivocally to injure axons in vivo is nitric oxide [77] and it will be important in future to identify potentially relevant factors in these cell cultures. We and others have previously provided evidence that axonal transport deficits, likely reflecting an energy insufficiency or signalling deficit, can lead to axonal degeneration [19, 20, 39, 57]. In myelinating CNS cultures, cells are suffused in high levels of glucose (25 mM) and pyruvate (1 mM) so the substrates for ATP synthesis are unlikely to be limiting. Nonetheless, if axonal ATP synthesis is attenuated or axonal Ca2+ levels are perturbed, for example through mitochondrial injury [13], this could, in principle, account for axonal demise. Future studies will provide mechanistic insight.

The reduction in the amount of myelin at 6 dpi was marked. In this paradigm, cultures were infected at a time when myelin is just forming (~ DIV 18) and the paucity of myelin at 6 dpi could reflect failure of myelin to form normally (dysmyelination) or loss of previously formed myelin (demyelination). The myelin that remained often appeared fragmented (Fig. 4) and many infected PLP/DM20 positive oligodendrocyte cell bodies lacked myelin sheaths. These observations tend to exclude the possibility that myelination is simply arrested. Rather, myelin changes probably represent a combination of the arrest of myelination and the degradation of previously established sheaths. Whether the latter represents a (i) primary pathology, (ii) secondary consequence of oligodendroglial cell death, (iii) secondary consequence of axonal loss or (iv) a combination thereof, remains to be determined.

Importantly, brain white matter is severely compromised in human newborns with congenital ZIKV syndrome caused by infection in the first trimester [12]. Chimelli et al. reported an almost complete lack of myelin and oligodendroglia (Olig 2 positive cells) in hemispheric white matter, and only rare myelinated fibres in the internal capsule and cerebellum in these babies. Axonal changes including spheroids (swellings) and Wallerian degeneration were observed in the brainstem and deep grey nuclei. In contrast, with the exception of the corticospinal tracts, spinal cord white matter appeared relatively normal. Our in vitro data suggest that reasons other than susceptibility to injury explain why spinal cord myelin was preserved in these cases; our CNS cultures are derived from spinal cord.

Spinal cord motor nerve loss has also been observed in newborns with congenital ZIKV syndrome [12, 51]. In contrast, in our spinal-cord derived cultures, neuronal cell death was unremarkable. In these dissociated cell cultures, region specific cell fate determinants are absent or mislocalised and ‘motor neurones’ do not innervate muscle. As a consequence, these cells are unlikely to express the full range of cell-type specific gene products produced in vivo, and this could potentially explain the different observations; although the short-term nature of the cultures is likely also a factor. It will be interesting to ascertain if the small subset of neurones that were infected in our cultures represent a motor neurone population.

In congenital ZIKV cases examined by Chemelli et al., DRGs, dorsal roots and the spinal cord dorsal column appeared normal [12] (the dorsal roots and dorsal columns carry the peripherally and centrally projecting fibres of DRG neurones). The study’s authors speculated the sensory system’s DRG neurones might be less susceptible to ZIKV infection than CNS cells due to their neural crest origin, as is the case for poliomyelitis and WNV encephalitis. Schwann cells are also of neural crest origin, and as demonstrated in the current study, are also much less susceptible to ZIKV than their CNS counterparts, which arise directly from the neural tube.

All major neural cell types are susceptible to infection by ZIKV

We observed ZIKV envelope protein by immunocytochemistry in all major CNS and PNS neural cell types, however there were marked differences in the susceptibility to infection. Few PNS cells were infected, whilst, in CNS cultures, oligodendrocytes were most susceptible and neurones least susceptible. Astrocytes and microglia displayed a dichotomous infectivity, being only slightly susceptible after short post infection times but markedly more vulnerable, relative to other cells, after long post infection times. Potentially, this could be due to uptake of infectious debris by these cells (for example, debris containing infectious viral RNA or virions). However, in an animal model infected on the day of birth, astrocytes were the first cell to be targeted, being ZIKV +ve at 4 days post infection [91], and the relevance of our observation remains to be ascertained.

ZIKV infection is enhanced in absence of a type I interferon response

The difference in susceptibility to ZIKV infection between WT and Ifnar1 KO CNS cultures was marked, as anticipated from previous work [17]. The type I interferon receptor is composed of two polypeptide chains, IFNAR1 and IFNAR2, and binds all type I interferons; the archetypal antiviral cytokines. In the CNS, astrocytes and microglia are thought to be the main source of type I interferons though there is some evidence that oligodendrocytes and neurones might also produce them [65]. Given the low level of infection by ZIKV in both WT and Ifnar1 KO PNS cultures, it was not possible to ascertain whether type I interferons play a role there too. The expression of interferon receptors in the PNS requires clarification.

Animal and cell culture models of flavivirus infection

Animal models and animal-derived cells are widely used for neuropathogenesis studies with flaviviruses. Among related neurotropic viruses, JEV has been reported to preferentially infect developing neurones in primary foetal rat brain culture [38] and secondary glial activation is involved in neuronal death [10]; however others have shown that astrocytes and microglia are also susceptible to infection [8, 98]. In mouse models, infection of glial cells and neurones has been described and the effects of type I interferons were studied in terms of the complex interplay between virus detection and subsequent responses [3, 9, 11, 24, 30, 35, 37, 44, 59, 61, 62, 76]. It has been speculated that microglia might act as a reservoir for JEV [84]. Whilst our data suggest ZIKV causes demyelination by direct infection, JEV-associated demyelination has been linked to auto immunity [89]. Some of these key observations have been reproduced in a primate model [60] and human microglia and neurones are also a target for JEV [36, 74, 85]. In the case of WNV, similar studies on tropism and host responses have been conducted [69, 81, 93]. Interestingly, astrocytes have been proposed as persistently infected reservoirs [16] whilst also mediating protective responses and suppression of virus (including WNV and ZIKV) replication [44]. Similar tropism and microglial activation have been described in primate models of WNV [34, 48], as well as in human cells where infection of neurones and glial cells as well as host/inflammatory responses to infection were investigated [7, 92].

Conclusions

Few data are available for ZIKV infection of the developing CNS or PNS, and our study sheds light on these processes. All cells of the CNS are susceptible to a degree. Recent studies on ZIKV tropism in human brain cell cultures suggest similar tropism (astrocytes, oligodendrocyte precursor cells, microglia and to a lesser extent neurones) [46, 70], demonstrating the relevance of our model. The protein AXL mediates entry into human microglia and astrocytes and modulates innate immune responses [50], confirming previous studies suggesting this host factor is important for ZIKV infection [45, 63]. However, although Axl mRNA is expressed in all major neural cell types in the mouse [94], recent studies suggest that AXL is not important for ZIKV infection in mice [33, 42]. Nonetheless, as our murine cultures mimic infection of the human nervous system, but in a readily quantifiable manner, it will be an important tool for studies of ZIKV pathogenesis.

Declarations

Acknowledgements

This study was funded by the UK Medical Research Council [MC_UU_12014, MR/N017552/1 (AK); ZIKA Rapid Response MC_PC_15105 (HW, JME, AK); MR/K501335/1 (Doctoral Training Grant; SLC)], National Centre for Replacement, Reduction and Refinement (NC/L000423/1; JME, CL) and Wellcome Trust (203680/Z/16/Z, WT092805; HJW). This project was partially funded through the European Union’s Horizon 2020 research and innovation programme under ZikaPLAN grant agreement No 734584 (HJW, JME, SB, CL).

Authors’ contributions

HW, JME and AK conceived the study and JME and AK directed the study; JME, HW, AK, SB and CL designed the study; JAB, SLC, MEC, DP, AJWS, SCB, JME, BB and VS carried out experimental work (co-ordinated by JAB and SLC); BB, RFOF, LJP and AK contributed reagents; JME collated data; JME, SLC, AK and HW interpreted data and wrote the paper. All authors edited and approved the final manuscript.

Competing interests

The authors declare they have no conflict of interest.

Compliance with ethical standards

Authority for use of experimental animals. Work was authorised by a UK Home Office Project Licence (PPL 60/4363) and approved by the Ethical Committee of the University of Glasgow and in compliance with guidelines from the National Centre for Replacement, Reduction and Refinement (NC3Rs) for the use of animals in research.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
MRC-University of Glasgow Centre for Virus Research
(2)
Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow
(3)
Oswaldo Cruz Foundation/Aggeu Magalhães Institute, Department of Virology, UFPE Campus-Cidade Universitária
(4)
Department of Neurogenetics, Max Planck Institute for Experimental Medicine

References

  1. Adams Waldorf KM, Stencel-Baerenwald JE, Kapur RP, Studholme C, Boldenow E, Vornhagen J, Baldessari A, Dighe MK, Thiel J, Merillat S, Armistead B, Tisoncik-Go J, Green RR, Davis MA, Dewey EC, Fairgrieve MR, Gatenby JC, Richards T, Garden GA, Diamond MS, Juul SE, Grant RF, Kuller L, Shaw DW, Ogle J, Gough GM, Lee W, English C, Hevner RF, Dobyns WB, Gale M Jr, Rajagopal L (2016) Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate. Nat Med 22:1256–1259. doi:10.1038/nm.4193 View ArticlePubMedPubMed CentralGoogle Scholar
  2. Adibi JJ, Marques ET Jr, Cartus A, Beigi RH (2016) Teratogenic effects of the Zika virus and the role of the placenta. Lancet 387:1587–1590. doi:10.1016/S0140-6736(16)00650-4 View ArticlePubMedGoogle Scholar
  3. Ashraf U, Zhu B, Ye J, Wan S, Nie Y, Chen Z, Cui M, Wang C, Duan X, Zhang H, Chen H, Cao S (2016) MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11. J Virol 90:4780–4795. doi:10.1128/JVI.02586-15 View ArticlePubMedPubMed CentralGoogle Scholar
  4. Bayless NL, Greenberg RS, Swigut T, Wysocka J, Blish CA (2016) Zika virus infection induces cranial neural crest cells to produce cytokines at levels detrimental for neurogenesis. Cell Host Microbe 20:423–428. doi:10.1016/j.chom.2016.09.006 View ArticlePubMedGoogle Scholar
  5. Boeuf P, Drummer HE, Richards JS, Scoullar MJ, Beeson JG (2016) The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impact. BMC Med 14:112. doi:10.1186/s12916-016-0660-0 View ArticlePubMedPubMed CentralGoogle Scholar
  6. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawche F (2016) Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387:1531–1539. doi:10.1016/S0140-6736(16)00562-6 View ArticlePubMedPubMed CentralGoogle Scholar
  7. Cheeran MC, Hu S, Sheng WS, Rashid A, Peterson PK, Lokensgard JR (2005) Differential responses of human brain cells to West Nile virus infection. J Neuro-Oncol 11:512–524. doi:10.1080/13550280500384982 Google Scholar
  8. Chen CJ, Chen JH, Chen SY, Liao SL, Raung SL (2004) Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol 78:12107–12119. doi:10.1128/JVI.78.22.12107-12119.2004 View ArticlePubMedPubMed CentralGoogle Scholar
  9. Chen CJ, Ou YC, Chang CY, Pan HC, Liao SL, Chen SY, Raung SL, Lai CY (2012) Glutamate released by Japanese encephalitis virus-infected microglia involves TNF-alpha signaling and contributes to neuronal death. Glia 60:487–501. doi:10.1002/glia.22282 View ArticlePubMedGoogle Scholar
  10. Chen CJ, Ou YC, Lin SY, Raung SL, Liao SL, Lai CY, Chen SY, Chen JH (2010) Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J Gen Virol 91:1028–1037. doi:10.1099/vir.0.013565-0 View ArticlePubMedGoogle Scholar
  11. Chen ST, Liu RS, Wu MF, Lin YL, Chen SY, Tan DT, Chou TY, Tsai IS, Li L, Hsieh SL (2012) CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality. PLoS Pathog 8:e1002655. doi:10.1371/journal.ppat.1002655 View ArticlePubMedPubMed CentralGoogle Scholar
  12. Chimelli L, Melo AS, Avvad-Portari E, Wiley CA, Camacho AH, Lopes VS, Machado HN, Andrade CV, Dock DC, Moreira ME, Tovar-Moll F, Oliveira-Szejnfeld PS, Carvalho AC, Ugarte ON, Batista AG, Amorim MM, Melo FO, Ferreira TA, Marinho JR, Azevedo GS, Leal JI, da Costa RF, Rehen S, Arruda MB, Brindeiro RM, Delvechio R, Aguiar RS, Tanuri A (2017) The spectrum of neuropathological changes associated with congenital Zika virus infection. Acta Neuropathol. doi:10.1007/s00401-017-1699-5
  13. Coleman M (2005) Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6:889–898. doi:10.1038/nrn1788 View ArticlePubMedGoogle Scholar
  14. Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JL, Guimaraes KP, Benazzato C, Almeida N, Pignatari GC, Romero S, Polonio CM, Cunha I, Freitas CL, Brandao WN, Rossato C, Andrade DG, Faria Dde P, Garcez AT, Buchpigel CA, Braconi CT, Mendes E, Sall AA, Zanotto PM, Peron JP, Muotri AR, Beltrao-Braga PC (2016) The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534:267–271. doi:10.1038/nature18296 PubMedPubMed CentralGoogle Scholar
  15. Dang J, Tiwari SK, Lichinchi G, Qin Y, Patil VS, Eroshkin AM, Rana TM (2016) Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell 19:258–265. doi:10.1016/j.stem.2016.04.014 View ArticlePubMedGoogle Scholar
  16. Diniz JA, Da Rosa AP, Guzman H, Xu F, Xiao SY, Popov VL, Vasconcelos PF, Tesh RB (2006) West Nile virus infection of primary mouse neuronal and neuroglial cells: the role of astrocytes in chronic infection. Am J Trop Med Hyg 75:691–696PubMedGoogle Scholar
  17. Donald CL, Brennan B, Cumberworth SL, Rezelj VV, Clark JJ, Cordeiro MT, Freitas de Oliveira Franca R, Pena LJ, Wilkie GS, Da Silva Filipe A, Davis C, Hughes J, Varjak M, Selinger M, Zuvanov L, Owsianka AM, Patel AH, McLauchlan J, Lindenbach BD, Fall G, Sall AA, Biek R, Rehwinkel J, Schnettler E, Kohl A (2016) Full genome sequence and sfrna interferon antagonist activity of Zika virus from Recife, Brazil. PLoS Negl Trop Dis 10:e0005048. doi:10.1371/journal.pntd.0005048 View ArticlePubMedPubMed CentralGoogle Scholar
  18. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jaaskelainen AJ, Smura T, Rosenberg A, Hill DA, DeBiasi RL, Vezina G, Timofeev J, Rodriguez FJ, Levanov L, Razak J, Iyengar P, Hennenfent A, Kennedy R, Lanciotti R, du Plessis A, Vapalahti O (2016) Zika Virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 374:2142–2151. doi:10.1056/NEJMoa1601824 View ArticlePubMedGoogle Scholar
  19. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR (2004) Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121–131. doi:10.1083/jcb.200312012 View ArticlePubMedPubMed CentralGoogle Scholar
  20. Edgar JM, Nave KA (2009) The role of CNS glia in preserving axon function. Curr Opin Neurobiol 19:498–504. doi:10.1016/j.conb.2009.08.003 View ArticlePubMedGoogle Scholar
  21. El Costa H, Gouilly J, Mansuy JM, Chen Q, Levy C, Cartron G, Veas F, Al-Daccak R, Izopet J, Jabrane-Ferrat N (2016) ZIKA virus reveals broad tissue and cell tropism during the first trimester of pregnancy. Sci Rep 6:35296. doi:10.1038/srep35296 View ArticlePubMedPubMed CentralGoogle Scholar
  22. Esposito S, Longo MR (2016) Guillain-Barre syndrome. Autoimmun Rev. doi:10.1016/j.autrev.2016.09.022
  23. Faizan MI, Abdullah M, Ali S, Naqvi IH, Ahmed A, Parveen S (2016) Zika virus-induced microcephaly and its possible molecular mechanism. Intervirology 59:152–158. doi:10.1159/000452950 View ArticlePubMedGoogle Scholar
  24. Fernandes NC, Nogueira JS, Ressio RA, Cirqueira CS, Kimura LM, Fernandes KR, Cunha MS, Souza RP, Guerra JM (2016) Experimental Zika virus infection induces spinal cord injury and encephalitis in newborn Swiss mice. Exp Toxicol Pathol. doi:10.1016/j.etp.2016.11.004
  25. Ferreira-de-Brito A, Ribeiro IP, Miranda RM, Fernandes RS, Campos SS, Silva KA, Castro MG, Bonaldo MC, Brasil P, Lourenco-de-Oliveira R (2016) First detection of natural infection of Aedes aegypti with Zika virus in Brazil and throughout South America. Mem Inst Oswaldo Cruz 111:655–658. doi:10.1590/0074-02760160332 View ArticlePubMedPubMed CentralGoogle Scholar
  26. Gabriel E, Ramani A, Karow U, Gottardo M, Natarajan K, Gooi LM, Goranci-Buzhala G, Krut O, Peters F, Nikolic M, Kuivanen S, Korhonen E, Smura T, Vapalahti O, Papantonis A, Schmidt-Chanasit J, Riparbelli M, Callaini G, Kronke M, Utermohlen O, Gopalakrishnan J (2017) Recent Zika virus isolates induce premature differentiation of neural progenitors in human brain organoids. Cell Stem Cell. doi:10.1016/j.stem.2016.12.005
  27. Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R, Nascimento JM, Brindeiro R, Tanuri A, Rehen SK (2016) Zika virus impairs growth in human neurospheres and brain organoids. Science 352:816–818. doi:10.1126/science.aaf6116 View ArticlePubMedGoogle Scholar
  28. Garcez PP, Nascimento JM, de Vasconcelos JM, Madeiro da Costa R, Delvecchio R, Trindade P, Loiola EC, Higa LM, Cassoli JS, Vitoria G, Sequeira PC, Sochacki J, Aguiar RS, Fuzii HT, de Filippis AM, JL d SGVJ, Tanuri A, Martins-de-Souza D, Rehen SK (2017) Zika virus disrupts molecular fingerprinting of human neurospheres. Sci Rep 7:40780. doi:10.1038/srep40780 View ArticlePubMedPubMed CentralGoogle Scholar
  29. Gatherer D, Kohl A (2016) Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol 97:269–273. doi:10.1099/jgv.0.000381 View ArticlePubMedGoogle Scholar
  30. Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, Sen E, Basu A (2007) Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55:483–496. doi:10.1002/glia.20474 View ArticlePubMedGoogle Scholar
  31. Goodfellow JA, Willison HJ (2016) Guillain-Barre syndrome: a century of progress. Nat Rev Neurol. doi:10.1038/nrneurol.2016.172
  32. Govero J, Esakky P, Scheaffer SM, Fernandez E, Drury A, Platt DJ, Gorman MJ, Richner JM, Caine EA, Salazar V, Moley KH, Diamond MS (2016) Zika virus infection damages the testes in mice. Nature. doi:10.1038/nature20556
  33. Hastings AK, Yockey LJ, Jagger BW, Hwang J, Uraki R, Gaitsch HF, Parnell LA, Cao B, Mysorekar IU, Rothlin CV, Fikrig E, Diamond MS, Iwasaki A (2017) TAM receptors are not required for Zika virus infection in mice. Cell Rep 19:558–568. doi:10.1016/j.celrep.2017.03.058 View ArticlePubMedGoogle Scholar
  34. He X, Ren J, Xu F, Ferguson MR, Li G (2009) Localization of West Nile Virus in monkey brain: double staining antigens immunohistochemically of neurons, neuroglia cells and West Nile Virus. Int J Clin Exp Pathol 3:156–161PubMedPubMed CentralGoogle Scholar
  35. Jiang R, Ye J, Zhu B, Song Y, Chen H, Cao S (2014) Roles of TLR3 and RIG-I in mediating the inflammatory response in mouse microglia following Japanese encephalitis virus infection. J Immunol Res 2014:787023. doi:10.1155/2014/787023 View ArticlePubMedPubMed CentralGoogle Scholar
  36. Kalia M, Khasa R, Sharma M, Nain M, Vrati S (2013) Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J Virol 87:148–162. doi:10.1128/JVI.01399-12 View ArticlePubMedPubMed CentralGoogle Scholar
  37. Kaushik DK, Gupta M, Kumawat KL, Basu A (2012) NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One 7:e32270. doi:10.1371/journal.pone.0032270 View ArticlePubMedPubMed CentralGoogle Scholar
  38. Kimura-Kuroda J, Ichikawa M, Ogata A, Nagashima K, Yasui K (1993) Specific tropism of Japanese encephalitis virus for developing neurons in primary rat brain culture. Arch Virol 130:477–484View ArticlePubMedGoogle Scholar
  39. Kiryu-Seo S, Ohno N, Kidd GJ, Komuro H, Trapp BD (2010) Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci 30:6658–6666. doi:10.1523/JNEUROSCI.5265-09.2010 View ArticlePubMedPubMed CentralGoogle Scholar
  40. Klase ZA, Khakhina S, Schneider Ade B, Callahan MV, Glasspool-Malone J, Malone R (2016) Zika fetal neuropathogenesis: etiology of a viral syndrome. PLoS Negl Trop Dis 10:e0004877. doi:10.1371/journal.pntd.0004877 View ArticlePubMedPubMed CentralGoogle Scholar
  41. Li C, Xu D, Ye Q, Hong S, Jiang Y, Liu X, Zhang N, Shi L, Qin CF, Xu Z (2016) Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19:672. doi:10.1016/j.stem.2016.10.017 View ArticlePubMedGoogle Scholar
  42. Li F, Wang PR, Qu LB, Yi CH, Zhang FC, Tang XP, Zhang LG, Chen L (2017) AXL is not essential for Zika virus infection in the mouse brain. Emerg Microbes Infect 6:e16. doi:10.1038/emi.2017.10 View ArticlePubMedPubMed CentralGoogle Scholar
  43. Li XF, Dong HL, Huang XY, Qiu YF, Wang HJ, Deng YQ, Zhang NN, Ye Q, Zhao H, Liu ZY, Fan H, An XP, Sun SH, Gao B, Fa YZ, Tong YG, Zhang FC, Gao GF, Cao WC, Shi PY, Qin CF (2016) Characterization of a 2016 clinical isolate of Zika virus in non-human Primates. EBioMedicine 12:170–177. doi:10.1016/j.ebiom.2016.09.022 View ArticlePubMedPubMed CentralGoogle Scholar
  44. Lindqvist R, Mundt F, Gilthorpe JD, Wolfel S, Gekara NO, Kroger A, Overby AK (2016) Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects. J Neuroinflammation 13:277. doi:10.1186/s12974-016-0748-7 View ArticlePubMedPubMed CentralGoogle Scholar
  45. Liu S, DeLalio LJ, Isakson BE, Wang TT (2016) AXL-mediated productive infection of human endothelial cells by Zika virus. Circ Res 119:1183–1189. doi:10.1161/CIRCRESAHA.116.309866 View ArticlePubMedGoogle Scholar
  46. Lum FM, Low DK, Fan Y, Tan JJ, Lee B, Chan JK, Rénia L, Ginhoux F, Ng LF (2017) Zika virus infects human fetal brain microglia and induces inflammation. Clin Infect Dis 64:914–920View ArticlePubMedGoogle Scholar
  47. Manangeeswaran M, Ireland DDC, Verthelyi D (2016) Zika (PRVABC59) infection is associated with T cell infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl/6 Mice. PLoS Pathog 12:e1006004View ArticlePubMedPubMed CentralGoogle Scholar
  48. Maximova OA, Faucette LJ, Ward JM, Murphy BR, Pletnev AG (2009) Cellular inflammatory response to flaviviruses in the central nervous system of a primate host. J Histochem Cytochem 57:973–989. doi:10.1369/jhc.2009.954180 View ArticlePubMedPubMed CentralGoogle Scholar
  49. McGrath EL, Rossi SL, Gao J, Widen SG, Grant AC, Dunn TJ, Azar SR, Roundy CM, Xiong Y, Prusak DJ, Loucas BD, Wood TG, Yu Y, Fernandez-Salas I, Weaver SC, Vasilakis N, Wu P (2017) Differential responses of human fetal brain neural stem cells to Zika virus infection. Stem Cell Reports. doi:10.1016/j.stemcr.2017.01.008
  50. Meertens L, Labeau A, Dejarnac O, Cipriani S, Sinigaglia L, Bonnet-Madin L, Le Charpentier T, Hafirassou ML, Zamborlini A, Cao-Lormeau VM, Coulpier M, Misse D, Jouvenet N, Tabibiazar R, Gressens P, Schwartz O, Amara A (2017) Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep 18:324–333. doi:10.1016/j.celrep.2016.12.045 View ArticlePubMedGoogle Scholar
  51. Melo AS, Aguiar RS, Amorim MM, Arruda MB, Melo FO, Ribeiro ST, Batista AG, Ferreira T, Dos Santos MP, Sampaio VV, Moura SR, Rabello LP, Gonzaga CE, Malinger G, Ximenes R, de Oliveira-Szejnfeld PS, Tovar-Moll F, Chimelli L, Silveira PP, Delvechio R, Higa L, Campanati L, Nogueira RM, Filippis AM, Szejnfeld J, Voloch CM, Ferreira OC Jr, Brindeiro RM, Tanuri A (2016) Congenital Zika virus infection: beyond neonatal microcephaly. JAMA Neurol. doi:10.1001/jamaneurol.2016.3720
  52. Miner JJ, Cao B, Govero J, Smith AM, Fernandez E, Cabrera OH, Garber C, Noll M, Klein RS, Noguchi KK, Mysorekar IU, Diamond MS (2016) Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165:1081–1091. doi:10.1016/j.cell.2016.05.008 View ArticlePubMedPubMed CentralGoogle Scholar
  53. Miner JJ, Sene A, Richner JM, Smith AM, Santeford A, Ban N, Weger-Lucarelli J, Manzella F, Ruckert C, Govero J, Noguchi KK, Ebel GD, Diamond MS, Apte RS (2016) Zika Virus infection in mice causes panuveitis with shedding of virus in tears. Cell Rep 16:3208–3218. doi:10.1016/j.celrep.2016.08.079 View ArticlePubMedPubMed CentralGoogle Scholar
  54. Misra UK, Kalita J (2010) Overview: Japanese encephalitis. Prog Neurobiol 91:108–120. doi:10.1016/j.pneurobio.2010.01.008 View ArticlePubMedGoogle Scholar
  55. Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodusek V, Vizjak A, Pizem J, Petrovec M, Avsic Zupanc T (2016) Zika virus associated with microcephaly. N Engl J Med 374:951–958. doi:10.1056/NEJMoa1600651 View ArticlePubMedGoogle Scholar
  56. Montgomery RR (2016) Age-related alterations in immune responses to West Nile virus infection. Clin Exp Immunol. doi:10.1111/cei.12863
  57. Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, Brown RH Jr, Brown H, Tiwari A, Hayward L, Edgar J, Nave KA, Garberrn J, Atagi Y, Song Y, Pigino G, Brady ST (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29:12776–12786. doi:10.1523/JNEUROSCI.3463-09.2009 View ArticlePubMedPubMed CentralGoogle Scholar
  58. Moura da Silva AA, Ganz JS, Sousa PD, Doriqui MJ, Ribeiro MR, Branco MD, Queiroz RC, Pacheco MJ, Vieira da Costa FR, Silva FS, Simoes VM, Pacheco MA, Lamy-Filho F, Lamy ZC, Soares de Britto EAMT (2016) Early growth and neurologic outcomes of infants with probable congenital zika virus syndrome. Emerg Infect Dis 22:1953–1956. doi:10.3201/eid2211.160956 View ArticlePubMedPubMed CentralGoogle Scholar
  59. Mukherjee S, Ghosh S, Nazmi A, Basu A (2015) RIG-I knockdown impedes neurogenesis in a murine model of Japanese encephalitis. Cell Biol Int 39:224–229. doi:10.1002/cbin.10354 View ArticlePubMedGoogle Scholar
  60. Myint KS, Kipar A, Jarman RG, Gibbons RV, Perng GC, Flanagan B, Mongkolsirichaikul D, Van Gessel Y, Solomon T (2014) Neuropathogenesis of Japanese encephalitis in a primate model. PLoS Negl Trop Dis 8:e2980. doi:10.1371/journal.pntd.0002980 View ArticlePubMedPubMed CentralGoogle Scholar
  61. Nazmi A, Dutta K, Das S, Basu A (2011) Japanese encephalitis virus-infected macrophages induce neuronal death. J NeuroImmune Pharmacol 6:420–433. doi:10.1007/s11481-011-9271-x View ArticlePubMedGoogle Scholar
  62. Nazmi A, Mukherjee S, Kundu K, Dutta K, Mahadevan A, Shankar SK, Basu A (2014) TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection. Neurobiol Dis 69:235–247. doi:10.1016/j.nbd.2014.05.036 View ArticlePubMedGoogle Scholar
  63. Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa C, Bershteyn M, Kriegstein AR (2016) Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell 18:591–596. doi:10.1016/j.stem.2016.03.012 View ArticlePubMedPubMed CentralGoogle Scholar
  64. Onorati M, Li Z, Liu F, Sousa AM, Nakagawa N, Li M, Dell'Anno MT, Gulden FO, Pochareddy S, Tebbenkamp AT, Han W, Pletikos M, Gao T, Zhu Y, Bichsel C, Varela L, Szigeti-Buck K, Lisgo S, Zhang Y, Testen A, Gao XB, Mlakar J, Popovic M, Flamand M, Strittmatter SM, Kaczmarek LK, Anton ES, Horvath TL, Lindenbach BD, Sestan N (2016) Zika virus disrupts Phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial Glia. Cell Rep 16:2576–2592. doi:10.1016/j.celrep.2016.08.038 View ArticlePubMedGoogle Scholar
  65. Owens T, Khorooshi R, Wlodarczyk A, Asgari N (2014) Interferons in the central nervous system: a few instruments play many tunes. Glia 62:339–355View ArticlePubMedGoogle Scholar
  66. Paivalainen S, Nissinen M, Honkanen H, Lahti O, Kangas SM, Peltonen J, Peltonen S, Heape AM (2008) Myelination in mouse dorsal root ganglion/Schwann cell cocultures. Mol Cell Neurosci 37:568–578. doi:10.1016/j.mcn.2007.12.005 View ArticlePubMedGoogle Scholar
  67. Perez S, Tato R, Cabrera JJ, Lopez A, Robles O, Paz E, Coira A, Sanchez-Seco MP, Vazquez A, Carballo R, Quintas C, Pousa A (2016) Confirmed case of Zika virus congenital infection, Spain, March 2016. Euro Surveill 21. doi:10.2807/1560-7917.ES.2016.21.24.30261
  68. Qian X, Nguyen HN, Song MM, Hadiono C, Ogden SC, Hammack C, Yao B, Hamersky GR, Jacob F, Zhong C, Yoon KJ, Jeang W, Lin L, Li Y, Thakor J, Berg DA, Zhang C, Kang E, Chickering M, Nauen D, Ho CY, Wen Z, Christian KM, Shi PY, Maher BJ, Wu H, Jin P, Tang H, Song H, Ming GL (2016) Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure. Cell 165:1238–1254. doi:10.1016/j.cell.2016.04.032 View ArticlePubMedPubMed CentralGoogle Scholar
  69. Quick ED, Leser JS, Clarke P, Tyler KL (2014) Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection. J Virol 88:13005–13014. doi:10.1128/JVI.01994-14 View ArticlePubMedPubMed CentralGoogle Scholar
  70. Retallack H, Di Lullo E, Arias C, Knopp KA, Laurie MT, Sandoval-Espinosa C, Mancia Leon WR, Krencik R, Ullian EM, Spatazza J, Pollen AA, Mandel-Brehm C, Nowakowski TJ, Kriegstein AR, DeRisi JL (2016) Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci U S A. doi:10.1073/pnas.1618029113
  71. Rust RS (2012) Human arboviral encephalitis. Semin Pediatr Neurol 19:130–151. doi:10.1016/j.spen.2012.03.002 View ArticlePubMedGoogle Scholar
  72. Sapparapu G, Fernandez E, Kose N, Cao B, Fox JM, Bombardi RG, Zhao H, Nelson CA, Bryan AL, Barnes T, Davidson E, Mysorekar IU, Fremont DH, Doranz BJ, Diamond MS, Crowe JE (2016) Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature. doi:10.1038/nature20564
  73. Sarno M, Sacramento GA, Khouri R, do Rosario MS, Costa F, Archanjo G, Santos LA, Nery N Jr, Vasilakis N, Ko AI, de Almeida AR (2016) Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl Trop Dis 10:e0004517. doi:10.1371/journal.pntd.0004517 View ArticlePubMedPubMed CentralGoogle Scholar
  74. Shen SC, Shen CI, Lin H, Chen CJ, Chang CY, Chen SM, Lee HC, Lai PS, Su HL (2014) Susceptibility of human embryonic stem cell-derived neural cells to Japanese encephalitis virus infection. PLoS One 9:e114990. doi:10.1371/journal.pone.0114990 View ArticlePubMedPubMed CentralGoogle Scholar
  75. Simonin Y, Loustalot F, Desmetz C, Foulongne V, Constant O, Fournier-Wirth C, Leon F, Moles JP, Goubaud A, Lemaitre JM, Maquart M, Leparc-Goffart I, Briant L, Nagot N, Van de Perre P, Salinas S (2016) Zika virus strains potentially display different infectious profiles in human neural cells. EBioMedicine 12:161–169. doi:10.1016/j.ebiom.2016.09.020 View ArticlePubMedPubMed CentralGoogle Scholar
  76. Smith DR, Hollidge B, Daye S, Zeng X, Blancett C, Kuszpit K, Bocan T, Koehler JW, Coyne S, Minogue T, Kenny T, Chi X, Yim S, Miller L, Schmaljohn C, Bavari S, Golden JW (2017) Neuropathogenesis of Zika virus in a highly susceptible immunocompetent mouse model after antibody blockade of type I interferon. PLoS Negl Trop Dis 11:e0005296. doi:10.1371/journal.pntd.0005296 View ArticlePubMedPubMed CentralGoogle Scholar
  77. Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470–476View ArticlePubMedGoogle Scholar
  78. Solbrig MV, Perng GC (2015) Current neurological observations and complications of dengue virus infection. Curr Neurol Neurosci Rep 15:29. doi:10.1007/s11910-015-0550-4 View ArticlePubMedGoogle Scholar
  79. Solomon T (2003) Recent advances in Japanese encephalitis. J Neuro-Oncol 9:274–283. doi:10.1080/13550280390194037 Google Scholar
  80. Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D (2016) Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823–826. doi:10.1126/science.aaf8505 View ArticlePubMedGoogle Scholar
  81. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS (2009) The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J Virol 83:9329–9338. doi:10.1128/JVI.00836-09 View ArticlePubMedPubMed CentralGoogle Scholar
  82. Thomson CE, Hunter AM, Griffiths IR, Edgar JM, McCulloch MC (2006) Murine spinal cord explants: a model for evaluating axonal growth and myelination in vitro. J Neurosci Res 84:1703–1715. doi:10.1002/jnr.21084 View ArticlePubMedGoogle Scholar
  83. Thomson CE, McCulloch M, Sorenson A, Barnett SC, Seed BV, Griffiths IR, McLaughlin M (2008) Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous system. Eur J Neurosci 28:1518–1535. doi:10.1111/j.1460-9568.2008.06415.x View ArticlePubMedPubMed CentralGoogle Scholar
  84. Thongtan T, Cheepsunthorn P, Chaiworakul V, Rattanarungsan C, Wikan N, Smith DR (2010) Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir. Microbes Infect 12:37–45. doi:10.1016/j.micinf.2009.09.013 View ArticlePubMedGoogle Scholar
  85. Thongtan T, Thepparit C, Smith DR (2012) The involvement of microglial cells in Japanese encephalitis infections. Clin Dev Immunol 2012:890586. doi:10.1155/2012/890586 View ArticlePubMedPubMed CentralGoogle Scholar
  86. Ticconi C, Pietropolli A, Rezza G (2016) Zika virus infection and pregnancy: what we do and do not know. Pathog Glob Health 110:262–268. doi:10.1080/20477724.2016.1234804 View ArticlePubMedGoogle Scholar
  87. Tripathi S, Balasubramaniam VR, Brown JA, Mena I, Grant A, Bardina SV, Maringer K, Schwarz MC, Maestre AM, Sourisseau M, Albrecht RA, Krammer F, Evans MJ, Fernandez-Sesma A, Lim JK, Garcia-Sastre A (2017) A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses. PLoS Pathog 13:e1006258. doi:10.1371/journal.ppat.1006258 View ArticlePubMedPubMed CentralGoogle Scholar
  88. Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML (2000) Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). BioTechniques 29(52):54Google Scholar
  89. Tseng YF, Wang CC, Liao SK, Chuang CK, Chen WJ (2011) Autoimmunity-related demyelination in infection by Japanese encephalitis virus. J Biomed Sci 18:20. doi:10.1186/1423-0127-18-20 View ArticlePubMedPubMed CentralGoogle Scholar
  90. Uncini A, Shahrizaila N, Kuwabara S (2016) Zika virus infection and Guillain-Barre syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2016-314310
  91. van den Pol AN, Mao G, Yang Y, Ornaghi S, Davis JN (2017) Zika virus targeting in the developing brain. J Neurosci. doi:10.1523/JNEUROSCI.3124-16.2017
  92. van Marle G, Antony J, Ostermann H, Dunham C, Hunt T, Halliday W, Maingat F, Urbanowski MD, Hobman T, Peeling J, Power C (2007) West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence. J Virol 81:10933–10949. doi:10.1128/JVI.02422-06 View ArticlePubMedPubMed CentralGoogle Scholar
  93. Vasek MJ, Garber C, Dorsey D, Durrant DM, Bollman B, Soung A, Yu J, Perez-Torres C, Frouin A, Wilton DK, Funk K, DeMasters BK, Jiang X, Bowen JR, Mennerick S, Robinson JK, Garbow JR, Tyler KL, Suthar MS, Schmidt RE, Stevens B, Klein RS (2016) A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534:538–543. doi:10.1038/nature18283 View ArticlePubMedPubMed CentralGoogle Scholar
  94. Wang J, Zhang H, Young AG, Qiu R, Argalian S, Li X, Wu X, Lemke G, Lu Q (2011) Transcriptome analysis of neural progenitor cells by a genetic dual reporter strategy. Stem Cells 29:1589–1600. doi:10.1002/stem.699 View ArticlePubMedPubMed CentralGoogle Scholar
  95. Wang JN, Ling F (2016) Zika virus infection and microcephaly: evidence for a causal link. Int J Environ Res Public Health 13. doi:10.3390/ijerph13101031
  96. White MK, Wollebo HS, David Beckham J, Tyler KL, Khalili K (2016) Zika virus: an emergent neuropathological agent. Ann Neurol 80:479–489. doi:10.1002/ana.24748 View ArticlePubMedPubMed CentralGoogle Scholar
  97. Winkelmann ER, Luo H, Wang T (2016) West Nile Virus Infection in the Central Nervous System. F1000Res 5. doi:10.12688/f1000research.7404.1
  98. Yang CM, Lin CC, Lee IT, Lin YH, Yang CM, Chen WJ, Jou MJ, Hsiao LD (2012) Japanese encephalitis virus induces matrix metalloproteinase-9 expression via a ROS/c-Src/PDGFR/PI3K/Akt/MAPKs-dependent AP-1 pathway in rat brain astrocytes. J Neuroinflammation 9:12. doi:10.1186/1742-2094-9-12 View ArticlePubMedPubMed CentralGoogle Scholar
  99. Zhang F, Hammack C, Ogden SC, Cheng Y, Lee EM, Wen Z, Qian X, Nguyen HN, Li Y, Yao B, Xu M, Xu T, Chen L, Wang Z, Feng H, Huang WK, Yoon KJ, Shan C, Huang L, Qin Z, Christian KM, Shi PY, Xu M, Xia M, Zheng W, Wu H, Song H, Tang H, Ming GL, Jin P (2016) Molecular signatures associated with ZIKV exposure in human cortical neural progenitors. Nucleic Acids Res 44:8610–8620. doi:10.1093/nar/gkw765 View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement